Log in  First Connection?

Oncology ImagingArchives

Study on heterogeneity of vascularity and cellularity via multiparametric MRI habitat imaging in breast cancer

 Published on 20/05/2025 |  Original article (Full-text)  | Zhang Xiaolei et al. | BMC Medical Imaging 2025; 25(1): 159

Breast cancer is not only the most prevalent malignancy worldwide, but also the leading cause of cancer-related death in women [1]. In fact, personalized medicine is crucial for improving the clinical outcomes of breast cancer patients [2, 3–4]. However, the high degree of inter-tumor and intra-tumor...

Prospective Cohort Study of Trastuzumab Biosimilar CT-P6 in HER2-Positive Gastric Cancer: Japanese Real-World Outcomes

 Published on 13/05/2025 |  Original article (Full-text)  | Hiroya Taniguchi   et al. | Oncology and Therapy 2025; aop: 10.1007/s40487-025-00341-7

Overexpression of the human epidermal growth factor receptor-2 (HER2) is involved in the proliferation of human tumor cells [1]. By introducing HER2-targeting molecules, beginning with trastuzumab for breast cancer [2], the clinical outcome of HER2-positive cancers, including breast cancer and gastric...

Whole-body CT scanning radiation improves the immune microenvironment of tumor tissues to enhance the antitumor effect of ICI

 Published on 06/05/2025 |  Original article (Full-text)  | Dong Jigang et al. | BMC Cancer 2025; 25(1): 823

Lung cancer is one of the malignant tumors with the highest morbidity [25]. and mortality rates worldwide, and clinically most of the lung cancer patients are already in advanced stages when they present with symptoms at the clinic, and the overall 5-year survival rate of advanced lung cancer patients...

Evaluation of 3D ARFI imaging of prostate cancer: diagnostic reliability and concordance with MpMRI

 Published on 29/04/2025 |  Original article (Full-text)  | Moavenzadeh Spencer R. et al. | Cancer imaging 2025; 25(1): 55

Prostate cancer (PCa) is the second most common cancer in men worldwide [1, 2]. PCa is typically detected with digital rectal examinations (DREs) and/or serum prostate-specific antigen (PSA) level testing. Positive DRE/PSA testing is typically followed by transrectal ultrasonography (TRUS)-guided biopsies....

Ultrasound-based radiomics for predicting the five major histological subtypes of epithelial ovarian cancer

 Published on 22/04/2025 |  Original article (Full-text)  | Yang Yang et al. | BMC Medical Imaging 2025; 25(1): 122

Ovarian cancer (OC) has the highest mortality among malignant tumours of female reproductive system [1], with about 52, 100 new cases and 22, 500 cancer-related deaths annually in China [2]. Epithelial ovarian cancers (EOCs) account for more than 85% of all OCs, while germ cell and sex cord stromal cell...

Oncology Imaging
 NaN min.

 Published on 14/11/2024 |  Original article (Full-text)  |